Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	162.14B
Revenue (ttm)	256.32B
Net Income (ttm)	15.17B
Shares Out	15.27M
EPS (ttm)	978.53
PE Ratio	10.85
Forward PE	11.50
Dividend	300.00 (2.85%)
Ex-Dividend Date	Dec 29, 2025

Volume	18,631
Average Volume	32,817
Open	10,620
Previous Close	10,540
Day's Range	10,510 - 10,620
52-Week Range	10,050 - 13,210
Beta	0.20
RSI	25.67
Earnings Date	Feb 13, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 601
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.